Löfgren's syndrome: human leukocyte antigen strongly influences the disease course
about
A concise review of pulmonary sarcoidosisGranuloma formation in pulmonary sarcoidosisSarcoidosis: Immunopathogenesis and Immunological MarkersMycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele, DRB1*1101.Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients.Development of a sarcoidosis murine lung granuloma model using Mycobacterium superoxide dismutase A peptide.Association of HLA-DRB1 with Sarcoidosis Susceptibility and Progression in African Americans.Granuloma genes in sarcoidosis: what is new?Solving the Conundrum: Immunogenetics of SarcoidosisSarcoidosis Presenting as Löfgren's Syndrome with Myopathy.High-Density Genetic Mapping Identifies New Susceptibility Variants in Sarcoidosis Phenotypes and Shows Genomic-driven Phenotypic Differences.Cardiac involvement in Caucasian patients with pulmonary sarcoidosis.Coexistence of Ankylosing Spondylitis and Löfgren's Syndrome.Update in diffuse parenchymal lung disease 2009.Bronchoalveolar lavage and other methods to define the human respiratory tract milieu in health and disease.HLA associations and Löfgren's syndrome.Therapy for sarcoidosis: evidence-based recommendations.Tuberculosis in the course of sarcoidosis treatment: is genotyping necessary for personalized therapy?The Clinical Features of Sarcoidosis: A Comprehensive Review.Sarcoidosis: a Critical Review of History and Milestones.Acute sarcoidosis: Löfgren's syndrome.Immunogenetics of Disease-Causing Inflammation in Sarcoidosis.Multisystemic diseases and ethnicity: a focus on lupus erythematosus, systemic sclerosis, sarcoidosis and Behçet disease.Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: Cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, Spain.[Musculoskeletal manifestations of sarcoidosis].Mass Cytometry Identifies Distinct Lung CD4+ T Cell Patterns in Löfgren's Syndrome and Non-Löfgren's Syndrome Sarcoidosis.Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients.Genetic, Immunologic, and Environmental Basis of Sarcoidosis.Sarcoidosis: a review for the internist.Higher levels of interleukin IL-17 and antigen-specific IL-17 responses in pulmonary sarcoidosis patients with Löfgren's syndrome.Associations between sarcoidosis clinical course and ANXA11 rs1049550 C/T, BTNL2 rs2076530 G/A, and HLA class I and II alleles.Sarcoidosis mortality in Sweden: a population-based cohort study.Clinical features of patients with homozygous complement C4A or C4B deficiency.HLA-alleles associated with increased risk for extra-pulmonary involvement in sarcoidosis
P2860
Q24609077-37326CC0-6F13-4A4B-9468-E2B298A09EDAQ26863703-6EE08474-01F6-4F16-B3D7-AD858EC9670CQ27006756-9538893F-08D3-46E6-8FE2-A64F272F52FFQ33651342-4D53457B-C128-4020-9085-32D8C0F4FFE2Q33758860-CB452767-933D-4E1D-AFD0-8C26BDB0B150Q34626531-33623433-FB5E-4731-A760-1A72893D3090Q36049206-B9CF631E-6839-4BE5-9488-6DD42728CAFFQ36057780-FE1CF890-2782-42D7-BD12-360663E044BBQ36128590-149359E8-D895-4718-ACA7-25B1CCA555B7Q36801538-A40E5469-DB48-428F-B25D-329F660247B6Q36916014-004C7597-BFA2-4C6E-9300-3613D0BDE68DQ37579537-3241B918-ECB3-40C0-B662-EB69DAEDB895Q37679545-F4106B08-D67A-4894-B0BE-C5A3E08648EEQ37739695-B95DAEDE-C01A-4F3C-8A3F-6E43C82C214FQ37847083-38102683-FF5A-4211-A969-E7CAF41BF0BCQ37965602-75889AF0-64ED-41EC-892F-CE2982EB69CCQ37965606-9C1D32D1-E6EA-4036-9B18-AA76E886D62DQ38096028-9E1CD717-5FFB-4949-963B-2474DE4382B4Q38255985-387AC830-08E4-4CFC-A901-6CBA5BE0B630Q38367437-2BD3EA56-FD74-4F2E-B05E-D7D15860A714Q38374225-CE416A12-4F17-4D1E-9F2B-72B64B06C17EQ38384482-2B9F39C9-73E3-4B5E-806D-57BF88456627Q39329240-88E8C8C9-AC45-409B-9905-D12905947B74Q40116548-3C3C8286-E19E-4102-812A-B02C4558B744Q40219307-408E67AC-0022-43E1-B872-53FCD7879156Q41684102-E7308D1B-ED21-411A-A93D-A9DB399848ACQ42068942-8FBF0E90-EBC4-400C-B34C-D287AF25A9D2Q47233198-5E151788-C90C-4FA6-985C-0A8C8B13CBF4Q47665654-86CAB5D6-77DB-4454-B18D-6AA859DDB2E8Q51714687-68DE68F3-C52A-4C22-87F7-311953BB8FB7Q51796555-18432B85-BFE1-40F0-AD45-C95E9C5714EFQ55228243-14CE59C8-44AC-4E66-A382-50E664A2A9D0Q55496667-53A352C4-2FF1-4D2C-946C-04665550BF4AQ57536972-BCFE37F4-4AB5-456C-B931-33C00D9F0DCE
P2860
Löfgren's syndrome: human leukocyte antigen strongly influences the disease course
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Löfgren's syndrome: human leukocyte antigen strongly influences the disease course
@ast
Löfgren's syndrome: human leukocyte antigen strongly influences the disease course
@en
Löfgren's syndrome: human leukocyte antigen strongly influences the disease course
@nl
type
label
Löfgren's syndrome: human leukocyte antigen strongly influences the disease course
@ast
Löfgren's syndrome: human leukocyte antigen strongly influences the disease course
@en
Löfgren's syndrome: human leukocyte antigen strongly influences the disease course
@nl
prefLabel
Löfgren's syndrome: human leukocyte antigen strongly influences the disease course
@ast
Löfgren's syndrome: human leukocyte antigen strongly influences the disease course
@en
Löfgren's syndrome: human leukocyte antigen strongly influences the disease course
@nl
P2860
P3181
P1476
Löfgren's syndrome: human leukocyte antigen strongly influences the disease course
@en
P2093
Johan Grunewald
P2860
P304
P3181
P356
10.1164/RCCM.200807-1082OC
P407
P577
2009-02-15T00:00:00Z